Trial | NCT04996290  Report issue

Title

Combined PENG and LFCN Block for Total Hip Arthroplasty
Combined Pericapsular Nerve Group (PENG) and Lateral Femoral Cutaneous Nerve (LFCN) Block for Total Hip Arthroplasty: A Randomized Controlled Trial

  • Phase

    N/A

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    40
A clinical trial investigating the effect of a combined locoregional anesthesia technique on the postoperative analgesia outcomes after a total hip arthroplasty. A PENG block will be used in combination with a LFCN block. The results will be compared to a control group that is solely treated with intravenous analgesia. This technique aims to provide improved pain scores after surgery without interference of revalidation.
Study Started
Jun 01
2020
Primary Completion
Sep 30
2020
Study Completion
Oct 01
2020
Last Update
Aug 09
2021

Procedure PENG + LFCN block

Regional anesthesia technique

  • Other names: pericapsular nerve group block, lateral femoral cutaneous nerve block

Drug Ropivacaine injection

Local anesthetic used for peripheral nerve block.

  • Other names: ropivacaine 0.375%

PENG + LFCN block Active Comparator

The participants in this group received a combined regional technique just before surgery: Pericapsular nerve group (PENG) block Lateral femoral cutaneus nerve (LFCN) block

No regional anesthesia No Intervention

Control group

Criteria 

Inclusion Criteria:

adult patients who underwent a primary total hip replacement under general anesthesia

Exclusion Criteria:

insulin dependent diabetes mellitus
chronic pain
severe dementia or mental retardation
allergy to local anesthetics
No Results Posted